Yael Teitz
- Virology top 10%
- HIV Research and Treatment 6
-
- HIV/AIDS drug development and treatment 4
-
- Virus-based gene therapy research 7
-
- T-cell and Retrovirus Studies 7
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Herpesvirus Infections and Treatments 4
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- Porphyrin Metabolism and Disorders 2
- Co-authors
- D RonenNaomi GoldfingerJohn L. RiggsDov SchwartzA. TraubLevana ShermanLyndon S. OshiroNatalie E. Cremer
- Cited by
- VirologyOncologyOrganic Chemistry
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Antiviral Research (2 papers)Experimental Cell Research (2 papers)
- Partner nations
- IsraelUnited States
In The Last Decade
Yael Teitz
28 papers receiving 326 citations
Peers
Comparison fields: 5 of 58
- Virology 44
- Oncology 110
- Organic Chemistry 100
- Infectious Diseases 56
- Toxicology 8
Countries citing papers authored by Yael Teitz
This map shows the geographic impact of Yael Teitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yael Teitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yael Teitz more than expected).
Fields of papers citing papers by Yael Teitz
This network shows the impact of papers produced by Yael Teitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yael Teitz. The network helps show where Yael Teitz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yael Teitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. | 1996 | 61 |
| 2 | 1994 | 69 | |
| 3 | 1994 | 29 | |
| 4 | 1994 | 2 | |
| 5 | 1994 | 2 | |
| 6 | 1992 | 13 | |
| 7 | 1990 | 3 | |
| 8 | 1988 | 9 | |
| 9 | 1987 | 19 | |
| 10 | 1985 | 6 | |
| 11 | 1984 | 16 | |
| 12 | 1981 | 3 | |
| 13 | 1980 | 3 | |
| 14 | 1979 | 5 | |
| 15 | 1974 | 1 | |
| 16 | 1971 | 23 | |
| 17 | Transformation and virus production in normal rat thymus cells and those infected with Moloney leukemia virus. | 1970 | 9 |
| 18 | 1969 | 1 | |
| 19 | 1968 | 4 | |
| 20 | 1968 | 11 |
About Yael Teitz
Yael Teitz is a scholar working on Virology, Immunology, Genetics, Hepatology and Biotechnology, having authored 28 papers that have together received 351 indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), T-cell and Retrovirus Studies (7 papers), HIV Research and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Herpesvirus Infections and Treatments (4 papers), HIV/AIDS drug development and treatment (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Porphyrin Metabolism and Disorders (2 papers). The work is most often cited by research in Virology (44 citations), Oncology (110 citations), Organic Chemistry (100 citations), Infectious Diseases (56 citations) and Toxicology (8 citations). Yael Teitz has collaborated with scholars based in Israel and United States. Frequent co-authors include D Ronen, Naomi Goldfinger, John L. Riggs, Dov Schwartz, A. Traub, Levana Sherman, Lyndon S. Oshiro, Natalie E. Cremer, Edwin H. Lennette and Shoshana Bar‐Nun. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Antiviral Research, Experimental Cell Research, JNCI Journal of the National Cancer Institute and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.